Biotech Values

[rkrw]

I missed it but thanks for the pointer. Yes, people love to point to the threat of litigation for everything. Cart before the horse, the trial hasn't even started yet. Let's see if it works in this new trial.

On Osiris valuation, genzyme partnered with them for a ton of money and for dorb, someone called sigma tau partnered with them for all of $1.5M upfront plus $4.5M in stock valued at about 18 cents. I'm sure genz did take a look at orbec and passed. So what can you say, sell short osiris and go long dorb if you have conviction genz made mistakes on both ends.